Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
804.33 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13,117.2 | 12,172.9 | 16,071.7 | 8,497.1 | 7,863.4 | 6,710.8 | 5,872.227 | 4,860.427 | 4,103.728 | 2,819.557 | 2,104.745 | 1,378.477 | 445.824 | 459.074 | 379.268 | 238.457 | 125.024 | 63.447 | 66.193 | 174.017 | 57.497 | 21.988 | 21.973 | 59.276 | 34.5 | 38.2 | 33.1 | 24.1 | 27.4 | 23.2 | 10.6 | 11.5 | 7.3 | 5 |
| Cost of Revenue
| 1,815.8 | 1,560.4 | 2,437.5 | 1,119.9 | 782.2 | 434.1 | 397.061 | 299.694 | 392.709 | 205.018 | 155.355 | 84.455 | 4.216 | 2.093 | 1.686 | 0.923 | 0 | 8.146 | 9.557 | 15.214 | 6.676 | 6.483 | 6.509 | 15.566 | 3.6 | 5 | 2.6 | 1.1 | 0 | 0 | 0 | 0 | 12.8 | 6.3 |
| Gross Profit
| 11,301.4 | 10,612.5 | 13,634.2 | 7,377.2 | 7,081.2 | 6,276.7 | 5,475.166 | 4,560.733 | 3,711.019 | 2,614.539 | 1,949.39 | 1,294.022 | 441.608 | 456.981 | 377.582 | 237.534 | 125.024 | 55.301 | 56.636 | 158.803 | 50.821 | 15.505 | 15.464 | 43.71 | 30.9 | 33.2 | 30.5 | 23 | 27.4 | 23.2 | 10.6 | 11.5 | -5.5 | -1.3 |
| Gross Profit Ratio
| 0.862 | 0.872 | 0.848 | 0.868 | 0.901 | 0.935 | 0.932 | 0.938 | 0.904 | 0.927 | 0.926 | 0.939 | 0.991 | 0.995 | 0.996 | 0.996 | 1 | 0.872 | 0.856 | 0.913 | 0.884 | 0.705 | 0.704 | 0.737 | 0.896 | 0.869 | 0.921 | 0.954 | 1 | 1 | 1 | 1 | -0.753 | -0.26 |
| Reseach & Development Expenses
| 4,439 | 3,592.5 | 2,908.1 | 2,735 | 3,036.6 | 2,186.1 | 2,075.142 | 2,052.295 | 1,620.577 | 1,271.353 | 859.947 | 625.554 | 529.506 | 489.252 | 398.762 | 278.016 | 201.613 | 137.064 | 155.581 | 136.095 | 136.024 | 124.926 | 91.54 | 56.256 | 44.9 | 37 | 27.8 | 28.3 | 23.3 | 39.7 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 1,556.2 | 1,320.433 | 1,177.697 | 838.526 | 504.755 | 329.415 | 210.755 | 117.261 | 65.201 | 52.923 | 49.348 | 37.865 | 25.892 | 25.476 | 17.062 | 14.785 | 12.532 | 9.607 | 8.309 | 6.4 | 5.8 | 5.8 | 5.9 | 5.8 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2,631.3 | 2,115.9 | 1,824.9 | 1,346 | 1,834.8 | 1,556.2 | 1,320.433 | 1,177.697 | 838.526 | 504.755 | 329.415 | 210.755 | 117.261 | 65.201 | 52.923 | 49.348 | 37.865 | 25.892 | 25.476 | 17.062 | 14.785 | 12.532 | 9.607 | 8.309 | 6.4 | 5.8 | 5.8 | 5.9 | 5.8 | 8.5 | 46.3 | 27.8 | 3.3 | 1.7 |
| Other Expenses
| 184 | -89.9 | -45.6 | -280.4 | 219.3 | 19.1 | -1.08 | -0.926 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -248.842 | 0 | 0 | 0 | 0 | 4.421 | 3.4 | 3 | 4.4 | 6.1 | 5.9 | 4.2 | 3.1 | 2 | 0.8 | 0.3 |
| Operating Expenses
| 7,068.2 | 5,618.5 | 4,687.4 | 3,800.6 | 4,871.4 | 3,742.3 | 3,395.575 | 3,229.992 | 2,459.103 | 1,776.108 | 1,189.362 | 836.309 | 646.767 | 554.453 | 451.685 | 327.364 | 239.478 | 162.956 | -67.785 | 153.157 | 150.809 | 137.458 | 101.147 | 68.986 | 54.7 | 45.8 | 38 | 40.3 | 35 | 52.4 | 49.4 | 29.8 | 4.1 | 2 |
| Operating Income
| 4,047.1 | 4,738.9 | 8,946.8 | 3,576.6 | 2,209.8 | 2,534.4 | 2,079.591 | 1,330.741 | 1,251.916 | 838.431 | 760.028 | 457.713 | -205.159 | -97.472 | -74.103 | -89.83 | -114.454 | -107.655 | 124.421 | 5.646 | -99.988 | -121.953 | -85.683 | -25.276 | -23.8 | -12.6 | -7.5 | -17.3 | -7.6 | -29.2 | -38.8 | -18.3 | -9.6 | -3.3 |
| Operating Income Ratio
| 0.309 | 0.389 | 0.557 | 0.421 | 0.281 | 0.378 | 0.354 | 0.274 | 0.305 | 0.297 | 0.361 | 0.332 | -0.46 | -0.212 | -0.195 | -0.377 | -0.915 | -1.697 | 1.88 | 0.032 | -1.739 | -5.546 | -3.899 | -0.426 | -0.69 | -0.33 | -0.227 | -0.718 | -0.277 | -1.259 | -3.66 | -1.591 | -1.315 | -0.66 |
| Total Other Income Expenses Net
| 152.2 | 119.9 | 379 | 233.8 | 219.3 | 19.1 | -1.08 | -0.926 | -26.819 | -62.684 | -29.69 | -43.292 | -17.733 | -6.996 | 2.151 | 9.471 | 8.854 | 4.505 | 28.975 | 36.053 | -7.47 | -2.424 | 9.503 | -4.575 | 1 | 4.3 | 6.2 | -14.3 | 7.6 | 0 | 0 | 0 | 5.2 | 0 |
| Income Before Tax
| 4,199.3 | 4,858.8 | 9,325.8 | 3,810.4 | 2,429.1 | 2,553.5 | 2,078.511 | 1,329.815 | 1,225.097 | 775.747 | 713.36 | 414.421 | -222.892 | -104.468 | -71.952 | -80.359 | -93.557 | -91.107 | 124.421 | 53.874 | -95.526 | -112.518 | -73.523 | -29.851 | -22.8 | -8.2 | -7.5 | -17.3 | -7.6 | 0 | 0 | 0 | -4.4 | 0 |
| Income Before Tax Ratio
| 0.32 | 0.399 | 0.58 | 0.448 | 0.309 | 0.381 | 0.354 | 0.274 | 0.299 | 0.275 | 0.339 | 0.301 | -0.5 | -0.228 | -0.19 | -0.337 | -0.748 | -1.436 | 1.88 | 0.31 | -1.661 | -5.117 | -3.346 | -0.504 | -0.661 | -0.215 | -0.227 | -0.718 | -0.277 | 0 | 0 | 0 | -0.603 | 0 |
| Income Tax Expense
| 245.7 | 520.4 | 1,250.5 | 297.2 | 313.3 | 109.1 | 880 | 434.293 | 589.041 | 427.673 | 288.998 | -335.848 | -1.132 | -2.122 | -4.122 | 2.351 | -29.751 | -21.866 | 178.846 | -84.281 | 3.008 | -7.011 | -21.663 | 2.514 | -1.7 | -8.4 | 7.5 | 29.4 | 30.6 | 1.5 | 1.1 | 0.8 | -10.3 | 0 |
| Net Income
| 3,953.6 | 4,338.4 | 8,075.3 | 3,513.2 | 2,115.8 | 2,444.4 | 1,198.511 | 895.522 | 636.056 | 348.074 | 424.362 | 750.269 | -221.76 | -104.468 | -67.83 | -82.71 | -105.6 | -102.337 | -95.446 | 41.699 | -107.458 | -124.377 | -76.18 | -23.215 | -23.1 | -8.6 | -11.6 | -32.4 | -23.5 | -30.7 | -39.9 | -19.1 | -4.5 | -3.3 |
| Net Income Ratio
| 0.301 | 0.356 | 0.502 | 0.413 | 0.269 | 0.364 | 0.204 | 0.184 | 0.155 | 0.123 | 0.202 | 0.544 | -0.497 | -0.228 | -0.179 | -0.347 | -0.845 | -1.613 | -1.442 | 0.24 | -1.869 | -5.657 | -3.467 | -0.392 | -0.67 | -0.225 | -0.35 | -1.344 | -0.858 | -1.323 | -3.764 | -1.661 | -0.616 | -0.66 |
| EPS
| 37.05 | 40.51 | 76.4 | 32.65 | 19.38 | 21.29 | 11.27 | 8.55 | 6.17 | 3.36 | 4.23 | 7.92 | -2.45 | -1.26 | -0.85 | -1.05 | -1.59 | -1.77 | -1.71 | 0.75 | -2.13 | -2.83 | -1.81 | -0.66 | -0.74 | -0.28 | -0.4 | -1.32 | -1.19 | -1.62 | -2.41 | -1.24 | -0.29 | -0.21 |
| EPS Diluted
| 34.77 | 38.22 | 71.97 | 30.52 | 18.46 | 21.29 | 10.34 | 7.7 | 5.52 | 2.98 | 3.72 | 6.75 | -2.45 | -1.26 | -0.85 | -1.05 | -1.59 | -1.77 | -1.71 | 0.74 | -2.13 | -2.83 | -1.81 | -0.66 | -0.73 | -0.28 | -0.4 | -1.32 | -1.19 | -1.62 | -2.41 | -1.24 | -0.29 | -0.21 |
| EBITDA
| 4,654.2 | 5,335.4 | 9,281 | 3,900.5 | 2,420.1 | 2,682.6 | 2,079.591 | 1,441.7 | 1,326.825 | 876.605 | 784.254 | 496.665 | -170.528 | -75.663 | -55.368 | -61.32 | -82.07 | -93.063 | 139.925 | -27.22 | -91.513 | -113.499 | -79.606 | -20.855 | -20.4 | -9.5 | -9.3 | -11.2 | -1.7 | -25 | -35.7 | -16.3 | -8.8 | -3 |
| EBITDA Ratio
| 0.355 | 0.425 | 0.584 | 0.455 | 0.281 | 0.378 | 0.354 | 0.274 | 0.305 | 0.297 | 0.361 | 0.332 | -0.46 | -0.212 | -0.158 | -0.377 | -0.991 | -1.728 | 1.494 | -0.156 | -1.592 | -5.591 | -4.176 | -0.275 | -0.62 | -0.366 | 0.009 | 0.129 | 0.474 | -1.078 | -3.368 | -1.417 | -1.918 | -0.6 |